Method to use gene expression to determine likelihood of clinical outcome of renal cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11776664
APP PUB NO 20210166790A1
SERIAL NO

16952566

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure provides gene and gene sets, the expression of which is important in the classification and/or prognosis of cancer, in particular of renal cell carcinoma.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GENOMIC HEALTH INCREDWOOD CITY CA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baehner, Frederick L San Francisco, US 10 58
Baker, Joffre Montara, US 21 316
Cowens, Wayne - 24 339
Goddard, Audrey San Francisco, US 2077 8865
Kiefer, Michael C Walnut Creek, US 60 710
Knezevic, Dejan Palo Alto, US 12 46
Maddala, Tara Sunnyvale, US 20 93
Shak, Steven Hillsborough, US 57 1135

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Apr 3, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 3, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 3, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00